{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:43:41Z","timestamp":1790819021895,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T00:00:00Z","timestamp":1513296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"DOI":"10.1093\/jac\/dkx486","type":"journal-article","created":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T23:16:33Z","timestamp":1511997393000},"page":"973-980","source":"Crossref","is-referenced-by-count":40,"title":["Characterization of the impact of rpoB mutations on the in vitro and in vivo competitive fitness of Clostridium difficile and susceptibility to fidaxomicin"],"prefix":"10.1093","volume":"73","author":[{"given":"Sarah A","family":"Kuehne","sequence":"first","affiliation":[{"name":"Clostridia Research Group, BBSRC\/EPSRC Synthetic Biology Research Centre (SBRC), School of Life Sciences, University of Nottingham, Nottingham, UK"},{"name":"Gastrointestinal and Liver Disorders Theme of the NIHR Nottingham Biomedical Research Centre (BRC), Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK"},{"name":"School of Dentistry, Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W","family":"Dempster","sequence":"additional","affiliation":[{"name":"Clostridia Research Group, BBSRC\/EPSRC Synthetic Biology Research Centre (SBRC), School of Life Sciences, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M","family":"Collery","sequence":"additional","affiliation":[{"name":"Clostridia Research Group, BBSRC\/EPSRC Synthetic Biology Research Centre (SBRC), School of Life Sciences, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimitray","family":"Joshi","sequence":"additional","affiliation":[{"name":"Clostridia Research Group, BBSRC\/EPSRC Synthetic Biology Research Centre (SBRC), School of Life Sciences, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Jowett","sequence":"additional","affiliation":[{"name":"Clostridia Research Group, BBSRC\/EPSRC Synthetic Biology Research Centre (SBRC), School of Life Sciences, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle L","family":"Kelly","sequence":"additional","affiliation":[{"name":"Clostridia Research Group, BBSRC\/EPSRC Synthetic Biology Research Centre (SBRC), School of Life Sciences, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Cave","sequence":"additional","affiliation":[{"name":"Clostridia Research Group, BBSRC\/EPSRC Synthetic Biology Research Centre (SBRC), School of Life Sciences, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris M","family":"Longshaw","sequence":"additional","affiliation":[{"name":"Astellas Pharma Europe Ltd, Chertsey, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9277-1261","authenticated-orcid":false,"given":"Nigel P","family":"Minton","sequence":"additional","affiliation":[{"name":"Clostridia Research Group, BBSRC\/EPSRC Synthetic Biology Research Centre (SBRC), School of Life Sciences, University of Nottingham, Nottingham, UK"},{"name":"Gastrointestinal and Liver Disorders Theme of the NIHR Nottingham Biomedical Research Centre (BRC), Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,12,15]]},"reference":[{"key":"key\n\t\t\t\t20180626060831_dkx486-B1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/1574-6968.12367","article-title":"Small animal models for the study of Clostridium difficile disease pathogenesis","volume":"352","author":"Hutton","year":"2014","journal-title":"FEMS Microbiol Lett"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B2","doi-asserted-by":"crossref","first-page":"e24894","DOI":"10.1371\/journal.pone.0024894","article-title":"Reconsidering the sporulation characteristics of hypervirulent Clostridium difficile BI\/NAP1\/027","volume":"6","author":"Burns","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B3","author":"US Department of Health and Human Services, CDC"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/sur.2010.080","article-title":"Best strategies in recurrent or persistent Clostridium difficile infection","volume":"12","author":"Cocanour","year":"2011","journal-title":"Surg Infect (Larchmt)"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B5","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2147\/TCRM.S4328","article-title":"Effects of treatment with antimicrobial agents on the human colonic microflora","volume":"4","author":"Rafii","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B6","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/cid\/cis462","article-title":"Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin","volume":"55","author":"Cornely","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B7","doi-asserted-by":"crossref","first-page":"e53757","DOI":"10.1371\/journal.pone.0053757","article-title":"Characterization of a stable, metronidazole-resistant Clostridium difficile clinical isolate","volume":"8","author":"Lynch","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B8","first-page":"23","article-title":"Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection","volume":"3","author":"Spigaglia","year":"2016","journal-title":"Ther Adv Infect Dis"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1155\/2015\/934594","article-title":"Fidaxomicin: a novel agent for the treatment of Clostridium difficile infection","volume":"26","author":"Zhanel","year":"2015","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B10","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1093\/cid\/cis358","article-title":"Fidaxomicin is an inhibitor of the initiation of bacterial RNA synthesis","volume":"55","author":"Artsimovitch","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1128\/AAC.01443-07","article-title":"OPT-80 eliminates Clostridium difficile and is sparing of Bacteroides species during treatment of C. difficile infection","volume":"53","author":"Louie","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B12","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1128\/AAC.00625-11","article-title":"Comparative susceptibilities to fidaxomicin (OPT-80) of isolates collected at baseline, recurrence, and failure from patients in two phase III trials of fidaxomicin against Clostridium difficile infection","volume":"55","author":"Goldstein","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.anaerobe.2009.09.005","article-title":"Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for Clostridium difficile infection","volume":"15","author":"Citron","year":"2009","journal-title":"Anaerobe"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.7326\/0003-4819-155-12-201112200-00007","article-title":"Comparative effectiveness of Clostridium difficile treatments: a systematic review","volume":"155","author":"Drekonja","year":"2011","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B15","author":"Seddon"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/jac\/dkt302","article-title":"In vitro selection, via serial passage, of Clostridium difficile mutants with reduced susceptibility to fidaxomicin or vancomycin","volume":"69","author":"Leeds","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B17","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1016\/j.cub.2013.01.013","article-title":"MarR family transcription factors","volume":"23","author":"Grove","year":"2013","journal-title":"Curr Biol"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/infdis\/jit426","article-title":"Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain","volume":"209","author":"Kuehne","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.anaerobe.2016.02.011","article-title":"Improving the reproducibility of the NAP1\/B1\/027 epidemic strain R20291 in the hamster model of infection","volume":"39","author":"Kelly","year":"2016","journal-title":"Anaerobe"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B20","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1099\/00221287-136-5-819","article-title":"Conjugative plasmid transfer from Escherichia coli to Clostridium acetobutylicum","volume":"136","author":"Williams","year":"1990","journal-title":"J Gen Microbiol"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B21","doi-asserted-by":"crossref","first-page":"e56051","DOI":"10.1371\/journal.pone.0056051","article-title":"Expanding the repertoire of gene tools for precise manipulation of the Clostridium difficile genome: allelic exchange using pyrE alleles","volume":"8","author":"Ng","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B22","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1128\/AAC.34.7.1348","article-title":"Quantitative study of antibiotic-induced susceptibility to Clostridium difficile enterocecitis in hamsters","volume":"34","author":"Larson","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B23","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1086\/320736","article-title":"Infection of hamsters with epidemiologically important strains of Clostridium difficile","volume":"183","author":"Sambol","year":"2001","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B24","volume-title":"Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria\u2014Eighth Edition: Approved Standard M11-A8","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mimet.2009.10.018","article-title":"The ClosTron: mutagenesis in Clostridium refined and streamlined","volume":"80","author":"Heap","year":"2010","journal-title":"J Microbiol Methods"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nature09397","article-title":"The role of toxin A and toxin B in Clostridium difficile infection","volume":"467","author":"Kuehne","year":"2010","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B27","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1093\/cid\/cis339","article-title":"Antimicrobial activities of fidaxomicin","volume":"55","author":"Goldstein","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B28","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1093\/cid\/cis337","article-title":"Fidaxomicin attains high fecal concentrations with minimal plasma concentrations following oral administration in patients with Clostridium difficile infection","volume":"55","author":"Sears","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B29","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1128\/AAC.01137-16","article-title":"Rifamycin resistance in Clostridium difficile is generally associated with a low fitness burden","volume":"60","author":"Dang","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B30","doi-asserted-by":"crossref","first-page":"14248","DOI":"10.1074\/jbc.M116.716704","article-title":"Rifampin resistance mutations are associated with broad chemical remodeling of Mycobacterium tuberculosis","volume":"291","author":"Lahiri","year":"2016","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B31","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ng.811","article-title":"Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection","volume":"43","author":"Ford","year":"2011","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B32","doi-asserted-by":"crossref","first-page":"7637","DOI":"10.1128\/AAC.01746-15","article-title":"Fitness cost of rifampin resistance in Neisseria meningitidis: in vitro study of mechanisms associated with RpoB H553Y mutation","volume":"59","author":"Colicchio","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060831_dkx486-B33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0167-7012(99)00089-5","article-title":"Estimation of temperature dependent growth rate and lag time of Listeria monocytogenes by optical density measurements","volume":"38","author":"Augustin","year":"1999","journal-title":"J Microbiol Methods"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/4\/973\/25087835\/dkx486.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:05:15Z","timestamp":1570406715000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/4\/973\/4748886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,15]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,12,15]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx486","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2017,12,15]]}}}